Table 2 Overall prescription-related changes following the intervention, and at 1 and 6 months
Drug prescription changes | Baseline | Postintervention | 1 month | 6 months |
|---|---|---|---|---|
Dose increase, n | 25 | 2 | 9 | |
Dose decrease, n | 34 | 11 | 6 | |
Discontinued, n | 216 | 15 | 43 | |
Newly prescribed drugs, n | 38 | 9 | 42 | |
Reintroduced drugs, n | 0 | 4 | 22 | |
Patients 0 PD, n (%) | 10 (4.00%) | 32 (12.80%) | 33 (13.31%) | 25 (11.06%) |
Patients 1–2 PD, n (%) | 122 (48.80%) | 151 (60.40%) | 144 (58.06%) | 134 (59.29%) |
Patients 3–4 PD, n (%) | 89 (35.60%) | 60 (24.00%) | 65 (26.21%) | 55 (24.34%) |
Patients > 4 PD, n (%) | 29 (11.60%) | 7 (2.80%) | 6 (2.42%) | 12 (5.31%) |
Number psychotropic drugs/patient, mean (SD) | 2.71 (1.47) | 1.95 (1.24) | 1.95 (1.26) | 2.06 (1.36) |
Difference (95% CI) | 0.755 (0.624–0.886)* p = 0.000 | 0.771 (0.635–0.908)* p = 0.000 | 0.634 (0.474–0.794)* p = 0.000 | |